| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Acorda Therapeutics, Inc. > News item |
Third Point sells shares of Acorda, keeps 4.1% stake
By Lisa Kerner
Charlotte, N.C., May 24 - Acorda Therapeutics, Inc. investors led by Third Point LLC sold 837,000 shares of the company's stock between March 30 and May 23, priced from $19.42 to $25.16.
The reporting persons beneficially own 1 million shares, or 4.1%, of the Hawthorne, N.Y.-based biopharmaceutical company.
On Feb. 22, Third Point reported holding 9.9% of the company's outstanding shares and recommended the company be sold, a previous SEC filing stated.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.